Literature DB >> 3092463

The cellular composition of granulomas in mesenteric lymph nodes from patients with Crohn's disease.

K Geboes, J van den Oord, C De Wolf-Peeters, V Desmet, P Rutgeerts, J Janssens, G Vantrappen, F Penninckx, R Kerremans.   

Abstract

The immunohistochemical findings in granulomatous lymphadenitis in patients with Crohn's disease are presented and compared with conventional light microscopic findings. The cellular composition of the granulomas in mesenteric lymph nodes was examined with a broad panel of monoclonal and polyclonal antibodies directed to B-cells, T-cells, monocytes/macrophages, dendritic reticulum cells, HLA-DR antigens and the transferrin receptor. The centre of the granulomas contains OKIa+, OKM1+, OKT9+, DRC-, To5- epithelioid cells and giant cells and OKT3+ lymphocytes. In general, the majority of the small lymphocytes within the granulomas expresses the OKT3+, OKT4+ Leu 3a+ phenotype which points toward T-helper cells. Fewer OKT3+ OKT8+ T suppressor/cytotoxic cells are observed. At the periphery of the granulomas a lymphocytic corona composed of BA1+, B1+ B lymphocytes may be present. From these findings it can be concluded that the granulomas in mesenteric lymph nodes from patients with Crohn's disease are composed of centrally located T-lymphocytes and of epithelioid cells which are of monocyte/macrophage origin and have the characteristics of antigen-presenting cells.

Entities:  

Mesh:

Year:  1986        PMID: 3092463     DOI: 10.1007/bf00713433

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  44 in total

1.  HISTOLOGY OF CROHN'S SYNDROME.

Authors:  W J WILLIAMS
Journal:  Gut       Date:  1964-12       Impact factor: 23.059

2.  Cicatrizing enteritis as a pathologic entity; analysis of 120 cases.

Authors:  S WARREN; S C SOMMERS
Journal:  Am J Pathol       Date:  1948-05       Impact factor: 4.307

3.  Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis.

Authors:  G Hellers
Journal:  Acta Chir Scand Suppl       Date:  1979

4.  Recurrence rate after surgical treatment of Crohn's disease.

Authors:  T Lindhagen; G Ekelund; L Leandoer; J Hildell; C Lindström; A Wenckert
Journal:  Scand J Gastroenterol       Date:  1983-11       Impact factor: 2.423

5.  A combined immunohistological and histochemical analysis of lymphocyte and macrophage subpopulations in the rheumatoid nodule.

Authors:  O L Duke; S Hobbs; G S Panayi; L W Poulter; J J Rasker; G Janossy
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

6.  A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

7.  Further characterization of the human inducer T cell subset defined by monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

8.  Granulomas do not affect postoperative recurrence rates in Crohn's disease.

Authors:  D M Wolfson; D B Sachar; A Cohen; J Goldberg; R Styczynski; A J Greenstein; I M Gelernt; H D Janowitz
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

9.  Veiled cells in chronic idiopathic inflammatory bowel disease.

Authors:  M M Wilders; H A Drexhage; M Kokjé; H W Verspaget; S G Meuwissen
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

10.  T cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies.

Authors:  R B Narayanan; L K Bhutani; A K Sharma; I Nath
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

View more
  12 in total

Review 1.  Do we really understand what the immunological disturbances in inflammatory bowel disease mean?

Authors:  Epameinondas V Tsianos; Konstantinos Katsanos
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

2.  The immunopathology of Schistosoma mansoni granulomas in human colonic schistosomiasis.

Authors:  K Geboes; I el-Dosoky; A el-Wahab; K Abou Almagd
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Changes in small intestinal epithelial expression of MHC class II antigen after terminal ileal resection for Crohn's disease.

Authors:  K Geboes; P Rutgeerts; F Penninckx; V Desmet; G Vantrappen
Journal:  Int J Colorectal Dis       Date:  1988-06       Impact factor: 2.571

4.  Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease.

Authors:  D Heresbach; J L Alexandre; B Branger; J F Bretagne; E Cruchant; A Dabadie; M Dartois-Hoguin; P M Girardot; H Jouanolle; J Kerneis; J C Le Verger; V Louvain; J Politis; M Richecoeur; M Robaszkiewicz; J A Seyrig
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

Review 5.  Convergence of non-communicable diseases and tuberculosis: a two-way street?

Authors:  M J Magee; A D Salindri; U P Gujral; S C Auld; J Bao; J S Haw; H-H Lin; H Kornfeld
Journal:  Int J Tuberc Lung Dis       Date:  2018-11-01       Impact factor: 2.373

Review 6.  Non-neoplastic histiocytic and dendritic cell disorders in lymph nodes.

Authors:  Caoimhe Egan; Elaine S Jaffe
Journal:  Semin Diagn Pathol       Date:  2017-11-03       Impact factor: 3.464

7.  Flow-cytometric evaluation of lymphocyte subpopulations in synchronously developing Schistosoma mansoni egg and Sephadex bead pulmonary granulomas.

Authors:  D G Remick; S W Chensue; J C Hiserodt; G I Higashi; S L Kunkel
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

Review 8.  Immunopathogenesis of granulomas in chronic autoinflammatory diseases.

Authors:  Wilhelmina Maria Cornelia Timmermans; Jan Alexander Michael van Laar; Petrus Martinus van Hagen; Menno Cornelis van Zelm
Journal:  Clin Transl Immunology       Date:  2016-12-16

9.  Emerging trends in the formation and function of tuberculosis granulomas.

Authors:  Geanncarlo Lugo-Villarino; D Hudrisier; A Benard; Olivier Neyrolles
Journal:  Front Immunol       Date:  2013-01-07       Impact factor: 7.561

10.  B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.

Authors:  Wilhelmina M C Timmermans; Jan A M van Laar; Tim B van der Houwen; Lieke S J Kamphuis; Sophinus J W Bartol; King H Lam; Rob J Ouwendijk; Miles P Sparrow; Peter R Gibson; P Martin van Hagen; Menno C van Zelm
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.